| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
Form 4: Liberman Alexander M., Chief Legal Officer
Received 798,680 shares as a grant or award · Exercised 1,271,078 Incentive Units of Medline Holdings, LP · Acquired 1,271,078 Common Units of Medline Holdings, LP (Option Exercise/Conversion) · 1 more |
| 16 Nov 2026 |
Form 4: Laabs Amanda H., Chief Product Officer
Received 520,127 shares as a grant or award · Exercised 820,000 Incentive Units of Medline Holdings, LP · Acquired 820,000 Common Units of Medline Holdings, LP (Option Exercise/Conversion) ($12.4M) · 1 more |
| 16 Nov 2026 |
Form 4: Golwas Douglas P, Chief Commercial Officer
Received 895,512 shares as a grant or award · Exercised 1,411,808 Incentive Units of Medline Holdings, LP · Acquired 1,411,808 Common Units of Medline Holdings, LP (Option Exercise/Conversion) ($21.3M) · 1 more |
| 16 Nov 2026 |
Form 4: Boyle James M, Director
Received 2,516,260 shares as a grant or award · Exercised 4,052,948 Incentive Units of Medline Holdings, LP · Acquired 4,052,948 Common Units of Medline Holdings, LP (Option Exercise/Conversion) · 1 more |
| 16 Nov 2026 | S-1 |
| 13 Nov 2026 | 144/A |
| 13 Nov 2026 | SCHEDULE 13G |
| 13 Nov 2026 | 144 |
| 06 Nov 2026 | SCHEDULE 13G/A |
| 04 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
NORTHFIELD, Ill., Nov. 4, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline” or the “Company”) (Nasdaq: MDLN), the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care3, today rep... |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 21 Oct 2026 |
8-K: Regulation FD Disclosure
On October 14, 2026, Medline Inc. (the “Company”) initiated a voluntary field action involving the removal, discontinuation, and market exit of all Medline Brand beds, including homecare beds, bariatric beds, and long-term care beds, as ... |
| 15 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On October 13, 2026, Joseph P. Baratta notified the Board of Directors (the “Board”) of Medline Inc. (the “Company”) of his decision to resign from the Board, effective as of December 31, 2026. Mr. Baratta’s decision coincides with his p... |
| 13 Oct 2026 |
Form 4: Gic Private Ltd, 10% owner and 2 others
Sold 7,816,987 shares ($275M) |
| 06 Oct 2026 |
Form 4: Gic Private Ltd, 10% owner and 2 others
Sold 9,717,940 shares ($336M) · Sold 1,688,690 shares ($60.4M) · Sold 9,272,000 shares ($325M) |
| 21 Aug 2026 |
Form 4: Boyle James M, Director
Granted 764,252 Incentive Units of Medline Holdings, LP |
| 21 Aug 2026 |
Form 4: Miller Stephen L, Chief Operating Officer
Granted 87,667 Incentive Units of Medline Holdings, LP |
| 17 Aug 2026 |
Form 4: Gic Private Ltd, 10% owner and 2 others
Sold 1,500,000 shares ($53.7M) · Sold 100,000 shares ($3.58M) |
| 11 Aug 2026 | SCHEDULE 13G/A |
Loading...